scPharmaceuticals Inc. (SCPH)

scPharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	159	225	197	137	145	105
Market Cap Growth	-44.21%	14.31%	43.24%	-4.98%	37.04%	51.05%
Enterprise Value	142	189	116	79	59	53
PE Ratio	-	-4.10	-5.34	-4.90	-4.49	-3.20
PS Ratio	9.04	16.54	-	-	-	-
PB Ratio	6.49	6.04	2.72	2.43	1.76	2.05
P/FCF Ratio	-2.99	-3.79	-5.69	-5.06	-5.22	-3.46
P/OCF Ratio	-2.99	-3.80	-5.69	-5.06	-5.22	-3.46
EV/Sales Ratio	8.04	13.91	-	-	-	-
EV/EBITDA Ratio	-3.34	-4.11	-3.50	-3.18	-2.03	-1.71
EV/EBIT Ratio	-3.30	-4.05	-3.45	-3.12	-2.01	-1.69
EV/FCF Ratio	-2.70	-3.19	-3.34	-2.93	-2.15	-1.74
Debt / Equity Ratio	1.66	1.08	0.52	0.31	0.25	0.39
Debt / EBITDA Ratio	-0.83	-0.87	-1.13	-0.70	-0.69	-0.66
Debt / FCF Ratio	-0.67	-0.68	-1.08	-0.65	-0.73	-0.67
Quick Ratio	5.21	6.13	15.96	5.08	11.29	13.90
Current Ratio	6.21	7.08	16.63	5.27	11.57	14.45
Asset Turnover	0.18	0.12	0	0	0	0
Interest Coverage	-5.98	-5.75	-10.16	-9.89	-11.45	-17.67
Return on Equity (ROE)	-132.40%	-97.20%	-76.20%	-42.50%	-39.60%	-54.30%
Return on Assets (ROA)	-58.70%	-49.60%	-49.00%	-31.10%	-29.90%	-39.40%
Return on Capital (ROIC)	-91.33%	-71.49%	-32.93%	-34.85%	-29.24%	-45.94%
Earnings Yield	-36.21%	-24.38%	-18.73%	-20.41%	-22.29%	-31.29%
FCF Yield	-37.96%	-26.37%	-17.59%	-19.78%	-19.16%	-28.86%
Buyback Yield / Dilution	-3.05%	-35.81%	-3.68%	-11.33%	-32.09%	-0.24%
Total Shareholder Return	-3.05%	-35.81%	-3.68%	-11.33%	-32.09%	-0.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).